Cargando…
Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan
This cross-sectional study examines the prevalence and necessity of antimicrobial drug use among patients who are hospitalized with COVID-19 infection in Japan.
Autores principales: | Komagamine, Junpei, Yabuki, Taku, Matsumoto, Kohei, Tanaka, Nao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857682/ https://www.ncbi.nlm.nih.gov/pubmed/35179589 http://dx.doi.org/10.1001/jamanetworkopen.2022.0040 |
Ejemplares similares
-
The effect of casirivimab with imdevimab on disease progression in nonsevere COVID‐19 patients in a single hospital in Japan
por: Komagamine, Junpei, et al.
Publicado: (2021) -
A trend in prevalence of antimicrobial use and appropriateness of antimicrobial therapy in an acute care hospital from 2018 to 2019: repeated prevalence surveys in Japan
por: Komagamine, Junpei, et al.
Publicado: (2019) -
Prevalence of antimicrobial use and active healthcare-associated infections in acute care hospitals: a multicentre prevalence survey in Japan
por: Komagamine, Junpei, et al.
Publicado: (2019) -
Incidence of thromboembolic complications in hospitalized COVID-19 patients in a medical ward in Japan: A single-center retrospective and prospective observational study
por: Komagamine, Junpei, et al.
Publicado: (2022) -
Initial symptoms of patients with coronavirus disease 2019 in Japan: A descriptive study
por: Komagamine, Junpei, et al.
Publicado: (2020)